306 results
8-K
EX-99.1
BMY
Bristol-Myers Squibb Co.
25 Apr 24
Bristol Myers Squibb Reports First Quarter Financial Results for 2024
7:47am
Myers Squibb's passion for making an impact extends beyond the discovery, development and delivery of innovative medicines that help patients prevail … , develop and deliver innovative medicines that help patients prevail over serious diseases. For more information about Bristol Myers Squibb, visit us
DEFA14A
BMY
Bristol-Myers Squibb Co.
22 Apr 24
Additional proxy soliciting materials
8:16am
Mission To discover, develop and deliver innovative medicines that help patients prevail over serious diseases. Our Values Innovation Passion … beyond discovery, development and delivery of innovative medicines. Our evolving ESG strategy builds on a legacy of comprehensive and global
8-K
EX-99.1
gp2 rckku
18 Mar 24
Strengthening Neuroscience Portfolio
8:56am
SC TO-T/A
EX-99
0c3h7efugz7kr7hgt
23 Feb 24
Third party tender offer statement (amended)
7:34am
8-K
EX-99.1
gtkxta p0
14 Feb 24
Bristol Myers Squibb Recommends Stockholders Reject “Mini-Tender” Offer by Tutanota LLC
4:32pm
SC TO-T/A
EX-99
defur78iv9xx 5vs
12 Feb 24
Third party tender offer statement (amended)
7:34am
8-K
EX-99.2
0mbikc alv4kbiinh
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
8-K
EX-99.1
xvrcq9xegh9dtp9d5ub
2 Feb 24
Bristol Myers Squibb Reports Fourth Quarter and Full-Year Financial Results for 2023
7:46am
SC TO-T
EX-99
q1yo0zet9l 3t4mmsof
25 Jan 24
Third party tender offer statement
8:13am
8-K
EX-99.1
19nnzjm0mfqd
8 Jan 24
Regulation FD Disclosure
10:29am
SC TO-C
EX-99.2
kpdf0qyht2ywt0g3gmq
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.5
81z9nu86afaiw9cw8sy5
26 Dec 23
Information about tender offer
4:22pm
SC TO-C
EX-99.1
avrte1tx
26 Dec 23
Information about tender offer
4:22pm
DFAN14A
EX-99.1
rp4zkx1k
22 Dec 23
Additional proxy materials by non-management
4:21pm
8-K
EX-99.1
uuvfh4
22 Dec 23
Bristol Myers Squibb Strengthens Neuroscience Portfolio with Acquisition of Karuna Therapeutics
4:15pm